Showing 81 - 100 results of 80,813 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (mean decrease)) ))', query time: 1.18s Refine Results
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91
  12. 92
  13. 93
  14. 94

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…A) Representative flow charts show gating strategy (left panel) based on size (Forward Scatter) and granularity (Side Scatter) of the cells, and (central and right panel) Carboxy-H<sub>2</sub>DCFDA signal. B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  15. 95

    Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

    Published 2015
    “…Cy5/Red, <i>C</i>. <i>parvum</i>; Cy3/green, SHP-2. …”
  16. 96
  17. 97

    FUD transiently decreased IOP in mice injected with Ad5-TGFβ2 viral vector. by Jennifer A. Faralli (4907311)

    Published 2020
    “…FUD significantly decreased IOP on Day 17 (2 days after it was injected on Day 15; *p<0.05). n = 6, 15, 13 and 12 for TGFβ2 only, TGFβ2 + FUD, TGFβ2 + PBS and TGFβ2 + mFUD treated eyes respectively. …”
  18. 98
  19. 99
  20. 100

    POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

    Published 2015
    “…<b>(B)</b> POS treatment downregulated the Intracellular ROS levels evaluated by H<sub>2</sub>DCFDA. Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t</i>-test, **<i>P</i> < 0.01, ***<i>P</i> < 0.001; ns, not significant. …”